UiPath is trading 13.9% down at $15.68 after its September 3 earnings disappointed investors. - Revenue beat estimates at $410.3 million, and full-year guidance was raised. - ARR growth was 12% to $1.938 billion, but net new ARR of $37 million showed modest sequential growth from $31 million in Q1 FY2027. - The sell-off was intensified by leadership changes and a recent rally, suggesting a company-specific, "sell-the-news" reaction as investors focused on the pace of AI monetization.